Brenntag AG (ETR:BNR) has earned an average recommendation of “Buy” from the six research firms that are covering the stock, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is €57.80 ($67.21).
BNR has been the topic of a number of recent research reports. Nord/LB set a €52.00 ($60.47) target price on shares of Brenntag and gave the stock a “neutral” rating in a research report on Thursday, May 31st. Baader Bank set a €62.00 ($72.09) price objective on shares of Brenntag and gave the company a “buy” rating in a research report on Tuesday, May 22nd. UBS Group set a €50.00 ($58.14) target price on shares of Brenntag and gave the company a “neutral” rating in a research note on Wednesday, July 4th. Kepler Capital Markets set a €63.00 ($73.26) target price on shares of Brenntag and gave the company a “buy” rating in a research note on Thursday, May 31st. Finally, Berenberg Bank set a €60.00 ($69.77) price objective on shares of Brenntag and gave the stock a “neutral” rating in a research note on Friday, July 6th.
Shares of ETR:BNR traded down €0.14 ($0.16) on Friday, reaching €52.44 ($60.98). 189,190 shares of the company traded hands.
Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.
Featured Story: How Do I Invest in Dividend Stocks
Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.